At the end of the latest market close, Aerpio Pharmaceuticals Inc. (ARPO) was valued at $1.16. In that particular session, Stock kicked-off at the price of $1.08 while reaching the peak value of $1.18 and lowest value recorded on the day was $1.08. The stock current value is $1.56.
Recently in News on May 17, 2021, Aerpio Reports First Quarter 2021 Financial Results and Provides Business Update. Ended first quarter 2021 with $39.0 million in cash and cash equivalents . You can read further details here
Aerpio Pharmaceuticals Inc. had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $2.1500 on 02/10/21, with the lowest value was $0.9541 for the same time period, recorded on 05/10/21.
Aerpio Pharmaceuticals Inc. (ARPO) full year performance was 59.45%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Aerpio Pharmaceuticals Inc. shares are logging -32.47% during the 52-week period from high price, and 122.86% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.70 and $2.31.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 60063394 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Aerpio Pharmaceuticals Inc. (ARPO) recorded performance in the market was 18.37%, having the revenues showcasing -42.86% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 50.60M, as it employees total of 12 workers.
Market experts do have their say about Aerpio Pharmaceuticals Inc. (ARPO)
During the last month, 0 analysts gave the Aerpio Pharmaceuticals Inc. a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 0 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 1.3861, with a change in the price was noted +0.3617. In a similar fashion, Aerpio Pharmaceuticals Inc. posted a movement of +34.78% for the period of last 100 days, recording 2,187,314 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for ARPO is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.
Technical breakdown of Aerpio Pharmaceuticals Inc. (ARPO)
Raw Stochastic average of Aerpio Pharmaceuticals Inc. in the period of last 50 days is set at 39.40%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 85.11%. In the last 20 days, the company’s Stochastic %K was 70.29% and its Stochastic %D was recorded 59.06%.
Bearing in mind the latest performance of Aerpio Pharmaceuticals Inc., several moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 18.37%. Additionally, trading for the stock in the period of the last six months notably deteriorated by -14.07%, alongside a boost of 59.45% for the period of the last 12 months. The shares increased approximately by 10.48% in the 7-day charts and went up by -3.33% in the period of the last 30 days. Common stock shares were lifted by -42.86% during last recorded quarter.